Study guide

12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions

AACN Cardiac Medicine Certification CMC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview and the CMC Test Plan

1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them

2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease

2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy

3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease

3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup

4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions

4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation

5 Chapter 5: Vascular Conditions and Vascular Interventions

5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications

6 Chapter 6: Shock States and Mechanical Circulatory Support

6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD

7 Chapter 7: Cardiac Procedures and Structural Heart Interventions

7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

8 Chapter 8: Cardiovascular Pharmacology

8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure

9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary

9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients

10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral

10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients

11 Chapter 11: Monitoring and Diagnostics

11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography

12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions

12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease

12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions

Key Takeaways Explain This Topic AI

Positive pressure ventilation reduces RV preload and reduces LV afterload, so the ventilated patient with LV failure often improves on positive pressure while the patient with RV failure, pulmonary hypertension or hypovolemia can decompensate on the same settings.

Pulse pressure variation above about 13% and stroke volume variation above about 13% predict fluid responsiveness only under strict conditions: fully controlled ventilation with no spontaneous effort, tidal volume at least 8 mL/kg predicted body weight, sinus rhythm, closed chest, and no severe RV failure.

A high peak inspiratory pressure with a normal plateau pressure is a resistance problem (secretions, bronchospasm, kinked or bitten tube); a high peak with a high plateau is a compliance problem (pneumothorax, pulmonary edema, atelectasis, abdominal distension, mainstem intubation).

Weaning-induced cardiac failure occurs when the switch from positive to negative intrathoracic pressure increases venous return and LV transmural pressure; look for a rising PAOP above 18 mmHg, hemoconcentration of 5% or more, hypertension, tachypnea and crackles during a spontaneous breathing trial.

Standard lung-protective targets are tidal volume 6-8 mL/kg predicted body weight (4-6 in ARDS), plateau pressure at or below 30 cmH2O, driving pressure at or below 15 cmH2O, and a rapid shallow breathing index below 105 breaths/min/L as one component of extubation readiness.

Last updated: August 2026

Modes, Set Variables, and Derived Variables

Every ventilator breath is defined by what triggers it, what limits it, and what cycles it off. The modes a CMC candidate must be able to interpret at the bedside are few.

Mode What is guaranteed What varies Typical cardiac use

Volume assist-control (VC-AC) Tidal volume and minimum rate; every triggered breath is a full breath Airway pressure varies with compliance and resistance Default for the unstable, sedated post-arrest or cardiogenic shock patient - guarantees minute ventilation

Pressure assist-control (PC-AC) Inspiratory pressure and minimum rate Tidal volume varies with compliance and effort Useful when plateau pressures are high; requires vigilance for falling tidal volume as compliance worsens

SIMV with pressure support A set number of mandatory breaths; spontaneous breaths supported Total minute ventilation Largely superseded; SIMV weaning is slower than daily spontaneous breathing trials

Pressure support ventilation (PSV) Inspiratory pressure support only, no set rate Rate, tidal volume, minute ventilation - all patient-driven The spontaneous breathing trial mode; requires reliable drive

APRV A high pressure held for a long time with brief releases Ventilation from releases plus spontaneous breathing Refractory hypoxemia; the high mean airway pressure can impair venous return and is poorly tolerated in RV failure

Variables the nurse or provider sets: tidal volume by predicted body weight (PBW), respiratory rate, FiO2, PEEP, inspiratory time or flow rate and pattern, and trigger sensitivity. Variables that result and must be measured: plateau pressure (an inspiratory hold), driving pressure (plateau minus total PEEP), auto-PEEP (an expiratory hold), minute ventilation, and exhaled tidal volume.

Predicted body weight is calculated from height and sex, not actual weight: men 50 + 2.3 x (height in inches - 60); women 45.5 + 2.3 x (height in inches - 60). Lung-protective targets are tidal volume 6-8 mL/kg PBW (4-6 mL/kg in ARDS), plateau pressure 30 cmH2O or less, and driving pressure 15 cmH2O or less . A rising plateau with an unchanged tidal volume means compliance is falling - in the cardiac patient that most often means worsening pulmonary edema.

Heart-Lung Interactions: The Cardiac-Specific Core

Spontaneous inspiration lowers intrathoracic pressure, which increases venous return and increases LV transmural pressure (afterload). Positive pressure ventilation does the reverse on both counts. Understanding that single inversion explains most of the hemodynamic behavior of ventilated cardiac patients.

Ventilator effect Right ventricle Left ventricle Net clinical result

Raised intrathoracic pressure Venous return and RV preload fall LV transmural pressure and afterload fall Improvement in decompensated LV failure; hypotension in hypovolemia or RV failure

High PEEP or lung overdistension Alveolar vessels compressed, PVR rises, RV afterload rises Reduced LV preload from impaired RV output RV dilation, septal shift, falling cardiac output in pulmonary hypertension or RV infarct

Very low lung volume with atelectasis Hypoxic vasoconstriction and vessel kinking raise PVR Hypoxemia PVR is lowest at functional residual capacity - both overinflation and derecruitment raise it

Loss of negative inspiratory swings RV filling less pulsatile LV no longer faces large negative-pressure afterload spikes Reduced myocardial oxygen demand and reduced work of breathing

Peri-Intubation Arrest

Induction and the first positive pressure breaths are the most dangerous 5 minutes in the shocked cardiac patient. Three insults land simultaneously: sedatives abolish sympathetic tone and cause vasodilation and negative inotropy, positive pressure abruptly removes venous return, and any pre-existing acidemia or hypoxemia is already limiting myocardial reserve. Nursing preparation reduces this risk concretely:

Resuscitate before you intubate : correct hypovolemia, and start or increase a vasopressor before induction rather than after the collapse.

Have push-dose vasopressor immediately available - phenylephrine 50-200 mcg or epinephrine 5-20 mcg IV - and a norepinephrine infusion primed and connected to a functioning central or reliable large-bore access.

Anticipate reduced induction doses in shock; ketamine 1-2 mg/kg (often 0.5-1 mg/kg in shock) or etomidate 0.2-0.3 mg/kg are preferred over propofol, which is a potent vasodilator and negative inotrope.

Preoxygenate well, use apneic oxygenation, and avoid aggressive bag-mask ventilation that stacks breaths and drops venous return further.

Hold or reduce vasodilator infusions such as nitroglycerin and nitroprusside immediately before induction.

Anticipate low initial tidal volume and rate with gentle initial pressures, and check blood pressure within 1 minute of the first ventilator breaths.

Auto-PEEP and Obstructive Shock

Auto-PEEP (dynamic hyperinflation, breath stacking) occurs when expiratory time is insufficient - high respiratory rate, high minute ventilation, bronchospasm, or a small endotracheal tube. Trapped alveolar gas raises intrathoracic pressure continuously, venous return falls, and the patient develops obstructive shock with rising peak pressures, an expiratory flow waveform that never returns to zero before the next breath, and difficulty triggering the ventilator. The immediate response is to disconnect the patient from the ventilator circuit and allow full exhalation with gentle chest compression ; blood pressure typically recovers within seconds, which is both the treatment and the diagnosis. Then reduce the set rate, shorten inspiratory time to lengthen expiration, treat bronchospasm, and consider raising set PEEP toward 80% of measured intrinsic PEEP to reduce triggering work in the obstructed patient.